Bio-therapeutic company Orthocell has received commitments to raise $13 million from a share placement and up to a further $5 million from a share purchase plan, primarily to accelerate the commercialisation of its CelGro flagship product.
04/12/2019 - 12:05
Orthocell to raise $18m
04/12/2019 - 12:05
![](https://images.businessnews.com.au/images/bn2020/bubble-arrow-border.png)